Summary
Pfizer Inc. (PFE) filed an 8-K on May 3, 2016, to report its financial results for the first quarter of 2016. The filing primarily consists of furnishing a press release that details these results. Investors should note that the information provided in this 8-K, including the attached press release, is furnished and not deemed 'filed' under Section 18 of the Exchange Act, meaning it does not carry the same legal liabilities. This is a common practice for disseminating earnings information without triggering specific filing requirements.
Key Highlights
- 1Pfizer announced its first-quarter 2016 financial results on May 3, 2016.
- 2The 8-K filing includes a press release detailing the Q1 2016 financial performance.
- 3The press release (Exhibit 99) is furnished, not filed, with the SEC.
- 4Information furnished under Item 2.02 is generally not subject to Section 18 of the Exchange Act liabilities.
- 5The filing's primary purpose is to make the Q1 2016 earnings announcement publicly available through SEC channels.